GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Proto Script Pharmaceutical PSCR · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Proto Script Pharmaceutical annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Five-year highlights

In USD.

FY2016FY2015FY2014
Revenue—$881,442$947,993
Operating income−$33,143−$146,686−$232,040
Net income−$33,143−$145,249−$239,217
Free cash flow−$38,210$32,009−$124,291
Total assets$11,750$198,941$453,713
Shareholders' equity−$77,062$62,242$323,517

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.